Clin2
NCT07535970Possibly a fitNot yet recruiting

Drug interaction study in healthy adults

Healthy Participants

This study is testing whether a common antifungal drug (itraconazole) affects how the body processes a new experimental medicine (HS-10506). The goal is to see if the two drugs can be used together safely.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
20 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • Be between 18 and 45 years old
  • Have a body mass index (BMI) between 19 and 26, with a minimum weight of 50 kg for men and 45 kg for women
  • Be generally healthy, with no serious medical conditions
  • Agree to use effective birth control and avoid pregnancy or sperm/egg donation for 3 months after the last dose
  • Avoid certain medications, supplements, and foods (like grapefruit) before and during the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07764692Not yet recruiting· Phase 1
How itraconazole affects the new drug hs-10504

This study tests how a medication called itraconazole affects the levels of a new drug called HS-10504 in your body. It aims to see if taking these together changes how the new drug is absorbed or processed, which helps decide safe dosing for future patients.

NCT07775261Recruiting· Phase 1
Testing a new drug in healthy volunteers

This study tests a new medicine called Lu AH69593 in healthy people to see how safe it is and how the body handles it. Participants will stay at the clinic for a short time. This is an early-stage trial, so it may not directly help you, but it helps develop future treatments.

Madison, Wisconsin
NCT07770217Not yet recruiting· Phase 1
Study of a new drug for healthy adults

This trial tests a new drug called HS-10504 in healthy adults to see how the body processes it. It is an early-phase study that helps determine safe dosing.

NCT07357610Recruiting· Phase 1
Drug interaction study of SIM0270 in healthy adults

This trial tests how SIM0270 interacts with other drugs (itraconazole, rifampin, midazolam) in healthy Chinese adults. It helps doctors understand if SIM0270 is safe and how it works in the body.

Jinan, Shandong
NCT07341672Not yet recruiting· Phase 1
How other medicines affect a new drug in healthy people

This study tests a new drug (clifutinib) in healthy volunteers to see how other common medicines (itraconazole, fluconazole, and efavirenz) affect its levels in the body. The results will help doctors understand how to dose clifutinib in future patients.

Jinan, Shandong
NCT07134465Enrolling by invitation· Phase 1
Drug interaction study of HSK31858 and itraconazole

This study checks if itraconazole changes how the body processes HSK31858. Healthy volunteers are needed to help understand the safety and drug levels.

Shanghai

Hear when a new Healthy Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.